IRVINE, Calif.--(BUSINESS WIRE)--California Stem Cell (CSC)’s Hans S. Keirstead, Ph.D., has recently been recognized as one of the top innovators in global health. This praise came in an article by genConnect highlighting six medical professionals making a difference in their respective sectors of the health industry. Dr. Keirstead was interviewed by genConnect’s creative director, Kelly Hayes, at the 2011 Aspen Ideas Festival.
The Aspen Ideas Festival is a week-long conference designed to promote intellectual exchange among some of the world’s most remarkable minds. Dr. Keirstead was invited to take part in the conference, which featured such distinguished speakers as Bill Gates, David Axelrod, Madeleine Albright, Lance Armstrong, and Alan Greenspan.
Dr. Keirstead will deliver a keynote address today at the Translational Strategies for Tissue Engineering conference in Boston, MA. His presentation will cover recent developments in cell-based treatments for otherwise incurable diseases. This presentation comes on the heels of CSC’s announcement last week that the company has acquired a cancer stem cell program for treatment of late stage metastatic melanoma, currently showing promising results in phase II clinical trials.
Later in the month, Dr. Keirstead will fly to Beijing, China to take part in the BIT’s 4th Annual World Congress of Regenerative Medicine and Stem Cell 2011, one of six conferences that CSC management and senior scientists will be speaking at in November.
Watch the genConnect video here: http://soc.li/i9iSEWM
Learn more about the Aspen Ideas Festival: http://www.aifestival.org/
About California Stem Cell
California Stem Cell Inc. (CSC) is an Irvine, CA based company which has developed proprietary methods to generate human embryonic stem cell (hESC) lines, expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and GMP processes. CSC is able to supply its human cell populations to companies and institutions worldwide for use in the development of therapies, efficacy screening or the creation of toxicity profiles for candidate drugs, and experimental research tools.
CSC is currently focused on the development of stem cell based therapies for spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s Disease), and metastatic cancers.
Follow us on Twitter: http://twitter.com/castemcell
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50053448&lang=en